MARKET

IGC

IGC

IGC Pharma Inc
AMEX
0.2720
-0.0070
-2.51%
After Hours: 0.2739 +0.0019 +0.70% 19:22 07/10 EDT
OPEN
0.2786
PREV CLOSE
0.2790
HIGH
0.2839
LOW
0.2693
VOLUME
462.23K
TURNOVER
--
52 WEEK HIGH
0.4985
52 WEEK LOW
0.2420
MARKET CAP
28.39M
P/E (TTM)
-4.2567
1D
5D
1M
3M
1Y
5Y
1D
IGC Pharma CEO, principal financial officer purchase over $1.15M of stock
TipRanks · 4d ago
IGC Pharma CEO, finance chief buy $1.15M of common stock
Seeking Alpha · 4d ago
IGC Pharma Says CEO Ram Mukunda And Principal Financial Officer Claudia Grimaldi Purchase Aggregate Of 4,274,853 Shares Directly From Company At $0.27/Shr
Benzinga · 4d ago
IGC Pharma Executives Convert Debt Into Equity Shares
TipRanks · 5d ago
Weekly Report: what happened at IGC last week (0629-0703)?
Weekly Report · 6d ago
Weekly Report: what happened at IGC last week (0622-0626)?
Weekly Report · 06/29 09:31
IGC Pharma announced beta version of Agentic Harmonization Assistant
TipRanks · 06/23 16:59
IGC Pharma Launches AI-Powered Data Harmonization Platform To Accelerate Alzheimer’s Research And Drug Discovery
Benzinga · 06/23 12:34
More
About IGC
IGC Pharma, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) to develop treatments for Alzheimer's and metabolic disorders. The Company's lead asset, IGC-AD1, is a cannabinoid-based therapy is in a Phase 2 trial (CALMA) for agitation in Alzheimer's dementia. The Company’s pipeline includes TGR-63, targeting amyloid plaques, and early-stage programs focused on neurodegeneration, tau proteins, and metabolic dysfunctions. The Company integrates AI to accelerate drug discovery, optimize clinical trials, and enhance patient targeting. It is also developing a Multimodal Interpretable Transformer for Alzheimer’s Disease (MINT-AD). MINT-AD leverages diverse data sources, including brain scans, genetics, lifestyle, and cognitive metrics, to produce clinically interpretable risk profiles and forecast decline trajectories.

Webull offers IGC Pharma Inc stock information, including AMEX: IGC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IGC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IGC stock methods without spending real money on the virtual paper trading platform.